Preferred Label : Peroxisome biogenesis disorder 7b;
Symbol : PBD7B;
CISMeF acronym : PBD7B;
Type : Phenotype, molecular basis known;
Description : The overlapping phenotypes of neonatal adrenoleukodystrophy (NALD) and infantile Refsum
disease (IRD) represent the milder manifestations of the Zellweger syndrome spectrum
(ZSS) of peroxisome biogenesis disorders. The clinical course of patients with the
NALD and IRD presentation is variable and may include developmental delay, hypotonia,
liver dysfunction, sensorineural hearing loss, retinal dystrophy, and visual impairment.
Children with the NALD presentation may reach their teens, and those with the IRD
presentation may reach adulthood (summary by Waterham and Ebberink, 2012). For a complete
phenotypic description and a discussion of genetic heterogeneity of PBD(NALD/IRD),
see 601539. Individuals with mutations in the PEX26 gene have cells of complementation
group 8 (CG8, equivalent to CGA). For information on the history of PBD complementation
groups, see 214100.;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the peroxisome biogenesis factor 26 gene (PEX26, 608666.0001);
Laboratory abnormalities : Low import of catalase by peroxisomes in patient fibroblasts (import increased or
restored by culturing at 30 degrees C); Normal but inefficient import of thiolase by peroxisomes in patient fibroblasts (numbers
of thiolase-positive peroxisomes increased by culturing at 30 degrees C);
Prefixed ID : #614873;
Origin ID : 614873;
UMLS CUI : C3553951;
Automatic exact mappings (from CISMeF team)
CISMeF manual mappings
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)